Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...
Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on its diabetes drug Victoza.
DeMo is an advanced multi-modal object Re-Identification (ReID) framework designed to tackle dynamic imaging quality variations across modalities. By employing decoupled features and a novel Attention ...
Sorry, Doom, Outside the Blocks could be my new favourite stress-buster, if this diorama-builder’s demo is anything to go by. Instead of ripping and tearing, this ...
Abstract: Humans can steadily and gently grasp unfamiliar objects based on tactile perception. Robots still face challenges in achieving similar performance due to the difficulty of learning accurate ...
What if the future of AI wasn’t a screen in your pocket but something as simple as a pen in your hand? The AI GRID explores how OpenAI’s ambitious new AI pen project, codenamed “Gumdrop,” could ...
2026 is set to be a year of transition for the Danish drugmaker, as it faces headwinds including lower pricing on multiple fronts and patent expiries in Brazil, Canada, and China. It follows a ...
The blockbuster weight-loss drug semaglutide and its rivals promise to help reverse the global obesity epidemic – if only more of the people who would benefit from these treatments could afford them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results